Legalon 70

Legalon 70

Legalon 70

Legalon 70 – capsules related to hepatoprotectors, which are recommended for toxic lesions for the supportive treatment of patients with chronic inflammatory liver diseases or cirrhosis. Read more about the features of the reception, the interaction with other drugs, read the instructions.


Indications for use (instruction): Legalon 70

Toxic liver damage for the supportive treatment of patients with chronic inflammatory liver disease or cirrhosis.

How to use

Adults and children over 12 years of age take 2 capsules 3 times a day. Capsules should be swallowed whole, without chewing, with a sufficient amount of liquid. The course of treatment is determined by the doctor individually, depending on the nature and course of the disease.

Children. There is not enough data regarding the use of this drug in children, so it should not be used in children under 12 years of age.


Hypersensitivity to the fruits of milk thistle, other components of the drug or to any of the excipients; acute poisoning of various etiologies.


Active ingredient: dry extract from the fruits of milk thistle (Silybum marianum);

1 capsule contains 86.5–93.3 mg of dry extract from the fruits of Milk Thistle (Silybum marianum) [36-44: 1], corresponds to 70 mg of silymarin (DNPH), or 54.1 mg of silymarin (TOP / DAB) in terms of on silibinin (solvent - ethyl acetate).

Excipients: polysorbate 80, povidone, attracts E421, sodium starch (type A), magnesium stearate, iron oxide red E172, black iron oxide E172, titanium dioxide E 171, gelatin, sodium lauryl sulfate.

Release form

Packaging. 10 capsules in a blister, 2 or 3, or 6 blisters in a cardboard box.

Dosage form. Capsules

Basic physico-chemical properties: brown hard gelatin capsule size 2 containing yellow powder.

Storage conditions

Store at a temperature not exceeding 30 °C out of the reach of children.


MADAUS GmbH, Lutticher Strasse 5, 53842 Troisdorf, Germany.

Registration certificate

No. 1449 dated 08/03/2018.

Registration Certificate No. UA/7185/01/02.

Advertising of the drug. Be sure to consult your doctor and read the package leaflet before using this medicine.
be worry

This section of the site contains information about medicines, their properties, methods of use, as well as other specialized information that is intended for healthcare professionals. The information on medicines contained in this section is not a guide for self-diagnosis and / or treatment. LLC SA Pro-Pharma is not responsible for possible negative consequences arising from the independent use of information from this section. Using the information from this section, you do it yourself, understanding that: self-medication can be harmful to your health, you must read the instructions and consult a doctor before using medicines.